CA2215160A1 - Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires - Google Patents

Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires Download PDF

Info

Publication number
CA2215160A1
CA2215160A1 CA002215160A CA2215160A CA2215160A1 CA 2215160 A1 CA2215160 A1 CA 2215160A1 CA 002215160 A CA002215160 A CA 002215160A CA 2215160 A CA2215160 A CA 2215160A CA 2215160 A1 CA2215160 A1 CA 2215160A1
Authority
CA
Canada
Prior art keywords
ridogrel
body weight
pharmaceutically acceptable
pharmaceutical composition
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002215160A
Other languages
English (en)
Inventor
Maria-Helena Joris Jozef Verlinden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2215160A1 publication Critical patent/CA2215160A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La présente invention se rapporte à l'utilisation du ridogrel dans la fabrication d'un médicament traitant des maladies intestinales inflammatoires, auquel cas le ridogrel est administré sous dose journalière de 0,01 mg/kg à 0,5 mg/kg de poids corporel; ainsi qu'aux compositions pharmaceutiques incluant le ridogrel.
CA002215160A 1995-03-28 1996-03-18 Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires Abandoned CA2215160A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200768.0 1995-03-28
EP95200768 1995-03-28

Publications (1)

Publication Number Publication Date
CA2215160A1 true CA2215160A1 (fr) 1996-10-03

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002215160A Abandoned CA2215160A1 (fr) 1995-03-28 1996-03-18 Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires

Country Status (10)

Country Link
EP (1) EP0817631A2 (fr)
JP (1) JPH10511097A (fr)
AR (1) AR002727A1 (fr)
AU (1) AU5397496A (fr)
CA (1) CA2215160A1 (fr)
HU (1) HUP9900309A3 (fr)
IL (1) IL117670A (fr)
NO (1) NO974486D0 (fr)
WO (1) WO1996030016A2 (fr)
ZA (1) ZA962461B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
EP1370244A1 (fr) * 2001-03-12 2003-12-17 Novo Nordisk A/S Nouveaux comprimes et gelules et procede de preparation correspondant
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
PT2396081T (pt) 2009-02-16 2017-07-11 Nogra Pharma Ltd Compostos alquilamido e suas utilizações
CA2864059C (fr) 2012-02-09 2020-04-28 Nogra Pharma Limited Methodes de traitement de la fibrose
BR112014026160A2 (pt) 2012-04-18 2017-07-18 Nogra Pharma Ltd métodos para tratar intolerância à lactose
WO2017046343A1 (fr) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions pour une administration par voie rectale dans le traitement de la colite ulcéreuse et leurs procédés d'utilisation
EA202192207A1 (ru) 2019-02-08 2021-10-27 Ногра Фарма Лимитед Способ получения 3-(4'-аминофенил)-2-метоксипропионовой кислоты и ее аналогов и промежуточных соединений

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
JPH10511097A (ja) 1998-10-27
EP0817631A2 (fr) 1998-01-14
ZA962461B (en) 1997-09-29
WO1996030016A2 (fr) 1996-10-03
IL117670A (en) 2000-02-29
HUP9900309A2 (hu) 1999-05-28
WO1996030016A3 (fr) 1997-01-30
NO974486L (no) 1997-09-29
AR002727A1 (es) 1998-04-29
NO974486D0 (no) 1997-09-29
AU5397496A (en) 1996-10-16
HUP9900309A3 (en) 1999-11-29
IL117670A0 (en) 1996-07-23
MX9707394A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
JP2614164B2 (ja) 抗腫瘍効果増強のための及び腫瘍治療のための組成物
EP1083931B1 (fr) Stabilisation de compositions contenant des inhibiteurs de l'enzyme de conversion d'angiotensine utilisant de l'oxyde de magnesium
CZ301737B6 (cs) Farmaceutický prípravek obsahující derivát benzamidu se zlepšenou rozpustností a orální absorptivitou
CZ287892A3 (en) Pharmaceutical preparations
AU2007341218B2 (en) Isosorbide mononitrate derivatives for the treatment of intestinal disorders
CA2215160A1 (fr) Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires
CA2144155A1 (fr) Combinaisons d'antagoniste des recepteurs h2 et d'ibuprofene
EP1092431B1 (fr) Compositions contenant du lasofoxifène
JPH07242626A (ja) 胃酸分泌抑制剤及び抗潰瘍剤
AU2011270133B2 (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
KR100192534B1 (ko) 소마토스타틴 분비증가제와 분비저하 억제제
JP2008533186A (ja) 腸炎治療のためのマクロライド類の使用
AU712071B2 (en) Anti-HIV composition containing imidazole derivatives
JP4737686B2 (ja) 新しい医薬
JPS641470B2 (fr)
CA1249521A (fr) Composes antiinflammatoires et methode de traitement
JP2004002454A (ja) 消化管運動抑制剤
JP3254712B2 (ja) 医薬組成物
US4812455A (en) Antiinflammatory compositions and methods
US4672061A (en) Antiinflammatory compositions and methods
MXPA97007394A (en) Formulations of low dose ridogrel and its use the treatment of inflamator intestinal diseases
KR20220152073A (ko) 피리메타민을 유효성분으로 포함하는 크론병의 치료 또는 예방용 약학 조성물
JPH10330265A (ja) 肝疾患治療剤
WO2010133907A1 (fr) Chélateurs hexadentate utilisables dans le cadre du traitement de la maladie intestinale inflammatoire
JPH0873348A (ja) 抗アレルギー剤

Legal Events

Date Code Title Description
FZDE Discontinued